“The Autologous CaTeVac Dendritic Cell Vaccine in Patients with Melanoma: Final Results of the DENDRON-01 Study” (2025) Voprosy onkologii, 71(4), p. OF-2437. doi:10.37469/0507-3758-2025-71-4-OF-2437.